/
Pharmaceutical preparations company · DE · FY ends Dec · Revenue $572K · -3635.49% margin · -$28M FCF
The business is unprofitable at the operating level (-5219.12% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 13.8% YoY with margins expanding 3490.9pp.
ROIC dropped from -48.85% to -58.79%, capital efficiency is deteriorating. Negative free cash flow of -$33M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$572K
▲ +13.8% YoY
Net Income (TTM)
-$18M
▲ +33.5% YoY
Op. Margin
-3635.49%
▲ +3490.9pp YoY
ROIC
-48.49%
▼ -9.9pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$28M
▲ +2.8% YoY
Op. Cash Flow (TTM)
-$28M
▲ +2.5% YoY
Net Debt
-$25M
Net Cash Position
Cash & Equiv.
$25M
5Y CAGR: -51.4%
Continue Research